Actualités réglementaires
31 août 2026•1 min de lecture
FDA Approves ANDA078249 for Torsemide Tablets by Aurobindo Pharma
The FDA has approved application ANDA078249 for torsemide oral tablets, manufactured by Aurobindo Pharma and Rising Pharma Holdings, covering strengths from 5 mg to 100 mg.
Actualités réglementaires
26 août 2026•1 min de lecture
FDA Approves Teva Torsemide Generic Tablets (ANDA 076346)
The FDA has approved Teva Pharmaceuticals’ ANDA 076346 for torsemide oral tablets in 5 mg, 10 mg, 20 mg and 100 mg strengths, prescription‑only.